INTECH Investment Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Sell
10,179
-1,704
-14% -$87.6K ﹤0.01% 1361
2026
Q1
$704K Sell
11,883
-7,250
-38% -$470K 0.01% 1175
2025
Q4
$1.18M Sell
19,133
-3,174
-14% -$194K 0.01% 1035
2025
Q3
$1.39M Sell
22,307
-5,000
-18% -$348K 0.01% 992
2025
Q2
$2.18M Hold
27,307
0.02% 711
2025
Q1
$2.35M Buy
27,307
+4,343
+19% +$356K 0.02% 673
2024
Q4
$1.79M Buy
22,964
+14,371
+167% +$1.12M 0.02% 774
2024
Q3
$620K Buy
+8,593
New +$609K 0.01% 1111

Other funds holding PBH

INTECH Investment Management's PBH Position: Q2 2026 in Review

INTECH Investment Management reduced its Prestige Consumer Healthcare (PBH) stake by 14% in Q2 2026, selling an estimated $87.6K and leaving 10,179 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #1361.

INTECH Investment Management first reported a position in PBH in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.35M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • INTECH Investment Management held 10,179 shares of Prestige Consumer Healthcare worth $481K as of Q2 2026.
  • INTECH Investment Management sold 1,704 Prestige Consumer Healthcare shares in Q2 2026, an estimated $87.6K.
  • Prestige Consumer Healthcare made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1361 holding.
  • INTECH Investment Management first reported a position in Prestige Consumer Healthcare in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Prestige Consumer Healthcare position peaked at $2.35M in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.